Feraccru

RSS

ferric maltol

Authorised
This medicine is authorised for use in the European Union.

Overview

Feraccru is an iron-containing medicine used to treat iron deficiency (lack of iron) in adults.

Feraccru contains the active substance ferric maltol.

This EPAR was last updated on 03/12/2019

Authorisation details

Product details
Name
Feraccru
Agency product number
EMEA/H/C/002733
Active substance
ferric maltol
International non-proprietary name (INN) or common name
ferric maltol
Therapeutic area (MeSH)
Anemia, Iron-Deficiency
Anatomical therapeutic chemical (ATC) code
B03AB
Publication details
Marketing-authorisation holder
Norgine B.V.
Revision
9
Date of issue of marketing authorisation valid throughout the European Union
18/02/2016
Contact address

Antonio Vivaldistraat 150
1083 HP Amsterdam
Netherlands

Product information

22/11/2019 Feraccru - EMEA/H/C/002733 - PSUSA/00010476/201902

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

ANTIANEMIC PREPARATIONS

Therapeutic indication

Feraccru is indicated in adults for the treatment of iron deficiency.

Assessment history

How useful was this page?

Add your rating
Average
1 rating
1 rating